Elías Herrero-Galán

Dr. Elías Herrero-Galán

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Cell
Verified
Journal Article
Closed access
JNJosé A. Nicolás-Ávila
José A. Nicolás-Ávila
ALAna V. Lechuga-Vieco
Ana V. Lechuga-Vieco
LELorena Esteban-Martínez
Lorena Esteban-Martínez
MSMaría Sánchez-Díaz
María Sánchez-Díaz
EGElena Díaz García
Elena Díaz García
AHAndrés Hidalgo
Andrés Hidalgo

10 February 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
MAMahmoud Abdellatif
Mahmoud Abdellatif
VTViktoria Trummer-Herbst
Viktoria Trummer-Herbst
FKFranziska Koser
Franziska Koser
SDSylvère Durand
Sylvère Durand
RARui Adão
Rui Adão
SSSedej Simon
Sedej Simon
The NAD + precursor nicotinamide improves diastolic dysfunction caused by aging, hypertension, or metabolic syndrome in rodents.

15 November 2024 in Science Advances
Verified
Journal Article
Open access
CHCarla Huerta-López
Carla Huerta-López
ACAlejandro Clemente-Manteca
Alejandro Clemente-Manteca
DVDiana Velázquez-Carreras
Diana Velázquez-Carreras
FEFrancisco M. Espinosa
Francisco M. Espinosa
JSJuan G. Sanchez
Juan G. Sanchez
JAJorge Alegre-Cebollada
Jorge Alegre-Cebollada
The mechanics of the extracellular matrix (ECM) determine cell activity and fate through mechanoresponsive proteins including Yes-associated protein 1 (YAP). Rigidity and viscous relaxation have emerged as the main mechanical properties of the ECM steering cell behavior. However, how cells integrate coexisting ECM rigidity and viscosity cues remains poorly understood, particularly in the high-stiffness regime. Here, we have exploited engineered stiff viscoelastic protein hydrogels to show that, contrary to current models of cell-ECM interaction, substrate viscous energy dissipation attenuates mechanosensing even when cells are exposed to higher effective rigidity. This unexpected behavior is however readily captured by a pull-and-hold model of molecular clutch–based cell mechanosensing, which also recapitulates opposite cellular response at low rigidities. Consistent with predictions of the pull-and-hold model, we find that myosin inhibition can boost mechanosensing on cells cultured on dissipative matrices. Together, our work provides general mechanistic understanding on how cells respond to the viscoelastic properties of the ECM.

30 May 2023 in Circulation
Verified
Journal Article
Closed access
FDFernando Domínguez
Fernando Domínguez
LLLaura Lalaguna
Laura Lalaguna
IMInés Martínez-Martín
Inés Martínez-Martín
JFJesús Piqueras Flores
Jesús Piqueras Flores
TRTorsten Bloch Rasmussen
Torsten Bloch Rasmussen
PGPablo García-Pavía
Pablo García-Pavía

1 June 2008 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Open access
PDF file
NCNelson Carreras-Sangra
Nelson Carreras-Sangra
EAElisa Alvarez-Garcia
Elisa Alvarez-Garcia
EHElías Herrero-Galán
Elías Herrero-Galán
JTJaime Tome-Amat
Jaime Tome-Amat
JLJavier Lacadena
Javier Lacadena
ÁMÁlvaro Martínez-del-Pozo
Álvaro Martínez-del-Pozo
Ribotoxins constitute a family of toxic extracellular fungal RNases that exert a highly specific activity on a conserved region of the larger molecule of rRNA, known as the sarcin – ricin loop. This cleavage of a single phosphodiester bond inactivates the ribosome and leads to protein synthesis inhibition and cell death. In addition to this ribonucleolytic activity, ribotoxins can cross lipid membranes in the absence of any known protein receptor. This ability is due to their capacity to interact with acid phospholipid-containing membranes. Both activities together explain their cytotoxic character, being rather specific when assayed against some transformed cell lines. The determination of high-resolution structures of some ribotoxins, the characterization of a large number of mutants, and the use of lipid model vesicles and transformed cell lines have been the tools used for the study of their mechanism of action at the molecular level. The present knowledge suggests that wild-type ribotoxins or some modified variants might be used in human therapies. Production of hypoallergenic mutants and immunotoxins designed against specific tumors stand out as feasible alternatives to treat some human pathology in the mid-term future.

1 February 2019 in Redox Biology
Verified
Journal Article
Open access
EHElías Herrero-Galán
Elías Herrero-Galán
IMInés Martínez-Martín
Inés Martínez-Martín
JAJorge Alegre-Cebollada
Jorge Alegre-Cebollada
The nanomechanics of sarcomeric proteins is a key contributor to the mechanical output of muscle. Among them, titin emerges as a main target for the regulation of the stiffness of striated muscle. In the last years, single-molecule experiments by Atomic Force Microscopy (AFM) have demonstrated that redox posttranslational modifications are strong modulators of the mechanical function of titin. Here, we provide an overview of the recent development of the redox mechanobiology of titin, and suggest avenues of research to better understand how the stiffness of molecules, cells and tissues are modulated by redox signaling in health and disease.